| ADA | adalimumab |
| αSMA | alpha-smooth muscle actin |
| BMI | Body Mass Index |
| CD31 | cluster of differentiation 31 |
| CST | cell signaling technology |
| CTRL | control tissue |
| DAPI | 4′,6-diamidino-2-phenylindole |
| ECM | extracellular matrix |
| EndMT | endothelial–mesenchymal transition |
| FAP | fibroblast activation protein |
| FFPE | formalin-fixed, paraffin-embedded |
| HiSCR | Hidradenitis Suppurativa Clinical Response |
| H&E | hematoxylin and eosin |
| HS | hidradenitis suppurativa |
| IHC | immunohistochemistry |
| IHS4 | International Hidradenitis Suppurativa Severity Score System 4 |
| IL | interleukin |
| IF | immunofluorescence |
| NIH | National Institutes of Health |
| PBS | phosphate-buffered saline |
| PDGFRα | platelet-derived growth factor receptor alpha |
| PECAM-1 | platelet endothelial cell adhesion molecule 1 |
| PFA | paraformaldehyde |
| ROI | region of interest |
| SD | standard deviation |
| SNAI1 | snail family transcriptional repressor 1 |
| Tie2 | tyrosine kinase with immunoglobulin and EGF homology domains 2 |
| TNF-α | tumor necrosis factor alpha |
| VEGF-A | vascular endothelial growth factor |
| vSMC | vascular smooth muscle cell |
| vWF | von Willebrand factor |
| WSI | whole-slide images |